A multivalent RSV vaccine based on the modified vaccinia Ankara vector shows moderate protection against disease caused by RSV in older adults in a phase 3 clinical study
Elke Jordan, Victoria A. Jenkins, Günter Silbernagl, Maria Paulina Velasco Chávez, Darja Schmidt, Frauke Schnorfeil, Stephanie A. Schultz, Liddy Chen, Fernanda Salgado, Jeanne‐Marie Jacquet, Tobias Welte, Laurence De Moerlooze
Topics & Concepts
VacciniaVirologyModified vaccinia AnkaraVector (molecular biology)DiseaseMedicineVirusBiologyImmunologyRecombinant DNAInternal medicineBiochemistryGeneRespiratory viral infections researchViral Infections and Immunology ResearchAnimal Virus Infections Studies